Developer docs
API playgroundTry for free, no card

Search company profiles

Carbometrics

Full company profile

uuid0002jhe

Namestring
Carbometrics
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Carbometrics is a Bristol, United Kingdom-based specialty chemistry and medical device company founded in 2018 that develops i-CAM, a continuous metabolic monitoring technology designed for use during cardiopulmonary bypass and organ perfusion procedures. The company is privately held, operates with a headcount in the 11-50 range, and positions itself at the intersection of chemistry-based sensing and clinical workflow applications in cardiac surgery and transplantation. Its core deliverable is a single product — i-CAM — described as the most comprehensive continuous metabolic monitor for cardiopulmonary bypass and organ perfusion circuits, with proprietary sensor technology as the principal differentiator relative to alternative monitoring approaches in this domain.

i-CAM is engineered to provide real-time metabolic monitoring throughout procedures such as open-heart surgery (where a heart-lung machine temporarily replaces cardiac and pulmonary function) and organ transplantation (where donor organs are preserved and transported on perfusion circuits). The technology is positioned as a domain-specialized solution rather than a general-purpose diagnostic platform, addressing a clinical gap in continuous metabolic visibility during these high-acuity procedures. No certifications, regulatory clearances, patents, or third-party validation are disclosed in the available material, indicating that i-CAM is likely still in development or pre-clinical validation stages.

The company's business model is currently oriented toward capital formation and partnership development rather than commercial sales. The company website explicitly states active outreach to clinical collaborators, OEM partners, and investors, and its only disclosed fundraising activity is approximately $2.5 million across two rounds in 2021 (led by SCVC, with Parkwalk Advisors, Ada Ventures, Selvedge Venture, and Télécom ParisTech participating). Pricing is not publicly disclosed, no distribution channels or named customers are listed, and the go-to-market motion appears to depend on OEM integration into larger medical device platforms paired with direct hospital engagement. Given this profile, the company is best characterized as pre-commercial, with revenue mechanics yet to be established.

Short descriptiontext

Carbometrics is a Bristol, UK-based medical device company developing i-CAM, a continuous metabolic monitor engineered for cardiopulmonary bypass and organ perfusion circuits used in cardiac surgery and organ transplantation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBristol, United Kingdom
HQ citystring
Bristol
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
continuous metabolic monitoring, cardiopulmonary bypass equipment, organ perfusion circuits, medical monitoring sensors, clinical chemistry devices
Industry3 codes
PRIMARYHLAHAHAG
Blood Glucose Monitoring (BGM) Meters & Test Strips
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAHAI
Ketone Monitoring (Blood/Urine) Devices & Strips
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Medical Monitoring Equipment
Social media profiles2 records
Cost components4 values
Technology or R&D, Personnel, Supply Chain, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Carbometrics develops i-CAM, a continuous metabolic monitoring system designed for use during cardiopulmonary bypass and organ perfusion procedures. The device delivers real-time metabolic monitoring in surgical and transplant settings, providing clinicians with continuous insight into a patient's metabolic state during critical medical procedures. The company is engaged with clinical collaborators, OEM partners, and investors to advance the product.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Carbometrics offers i-CAM, a single unified product serving as a comprehensive continuous metabolic monitoring solution specifically designed for cardiopulmonary bypass and organ perfusion circuits in medical settings.

Product and service1 record
1i-CAM
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Abbott
TypeDirect peer
Description

Abbott's i-STAT system is the dominant point-of-care blood gas and metabolite analyzer used in operating rooms including during cardiac surgery. It is the closest direct analog in terms of metabolic-parameter measurement in perioperative settings and a logical competitor/partner for Carbometrics' i-CAM.

TypeBroad incumbent
Description

Medtronic has a broad cardiac surgery and patient-monitoring portfolio (including perfusion and biosensing) that is broadly comparable to where Carbometrics' technology would integrate. It represents a major incumbent competitor and potential strategic acquirer.

TypeBroad incumbent
Description

LivaNova is a major manufacturer of cardiopulmonary bypass equipment and heart-lung machines, overlapping with Carbometrics' integration target. It is a logical OEM partner and potential acquirer for continuous metabolic monitoring capability within perfusion circuits.

TypeBroad incumbent
Description

Edwards Lifesciences is the established leader in hemodynamic monitoring (FloTrac, ClearSight, HemoSphere) in surgical and ICU settings. It is a relevant competitor in the operating-room monitoring space and a probable strategic acquirer of complementary monitoring technology.

TypeBroad incumbent
Description

Masimo is a leader in non-invasive patient monitoring technology (e.g., SET pulse oximetry) and has expanded into the operating room with multi-parameter monitoring. It is a broad incumbent competitor and convergence target for perioperative monitoring.

TypeDirect peer
Description

OPTI Medical manufactures point-of-care blood gas and metabolite analyzers (OPTI CCA-TS) used in operating rooms and critical care. It competes in the same intraoperative metabolic-monitoring space targeted by i-CAM.

TypeDirect peer
Description

Nova Biomedical manufactures Stat Profile and Prime Plus critical-care blood gas analyzers measuring glucose, lactate, and other metabolites at the point of care. Its products compete directly in the same perioperative metabolite-monitoring space as Carbometrics' i-CAM.

TypeDirect peer
Description

Siemens Healthineers' RAPIDPoint blood gas analyzers provide critical-care metabolite measurements in surgical and ICU settings, directly comparable to the continuous metabolic monitoring Carbometrics targets with i-CAM.

9Terumo Cardiovascular
TypeBroad incumbent
Description

Terumo Cardiovascular is the leading manufacturer of cardiopulmonary bypass systems — the exact circuits Carbometrics' i-CAM is designed to integrate with. As the dominant perfusion OEM, it is the most important commercial partner and a natural strategic acquirer of continuous metabolic monitoring capability.

TypeDirect peer
Description

Werfen's GEM Premier blood gas and metabolite analyzers are widely used in cardiac surgery and critical care, competing in the same intraoperative metabolic-monitoring category as Carbometrics' i-CAM.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Carbometrics

Medical Monitoring Equipmentcarbometrics.com

Carbometrics is a Bristol, UK-based medical device company developing i-CAM, a continuous metabolic monitor engineered for cardiopulmonary bypass and organ perfusion circuits used in cardiac surgery and organ transplantation.

What Carbometrics does

Carbometrics is a Bristol, United Kingdom-based specialty chemistry and medical device company founded in 2018 that develops i-CAM, a continuous metabolic monitoring technology designed for use during cardiopulmonary bypass and organ perfusion procedures. The company is privately held, operates with a headcount in the 11-50 range, and positions itself at the intersection of chemistry-based sensing and clinical workflow applications in cardiac surgery and transplantation. Its core deliverable is a single product — i-CAM — described as the most comprehensive continuous metabolic monitor for cardiopulmonary bypass and organ perfusion circuits, with proprietary sensor technology as the principal differentiator relative to alternative monitoring approaches in this domain.

i-CAM is engineered to provide real-time metabolic monitoring throughout procedures such as open-heart surgery (where a heart-lung machine temporarily replaces cardiac and pulmonary function) and organ transplantation (where donor organs are preserved and transported on perfusion circuits). The technology is positioned as a domain-specialized solution rather than a general-purpose diagnostic platform, addressing a clinical gap in continuous metabolic visibility during these high-acuity procedures. No certifications, regulatory clearances, patents, or third-party validation are disclosed in the available material, indicating that i-CAM is likely still in development or pre-clinical validation stages.

The company's business model is currently oriented toward capital formation and partnership development rather than commercial sales. The company website explicitly states active outreach to clinical collaborators, OEM partners, and investors, and its only disclosed fundraising activity is approximately $2.5 million across two rounds in 2021 (led by SCVC, with Parkwalk Advisors, Ada Ventures, Selvedge Venture, and Télécom ParisTech participating). Pricing is not publicly disclosed, no distribution channels or named customers are listed, and the go-to-market motion appears to depend on OEM integration into larger medical device platforms paired with direct hospital engagement. Given this profile, the company is best characterized as pre-commercial, with revenue mechanics yet to be established.

Carbometrics firmographics

Firmographics
Name
Carbometrics
Website
https://carbometrics.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Carbometrics is a Bristol, UK-based medical device company developing i-CAM, a continuous metabolic monitor engineered for cardiopulmonary bypass and organ perfusion circuits used in cardiac surgery and organ transplantation.
Ownership category
akta.pro rank

Carbometrics industry classification

Industry
Product category
Medical Monitoring Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAHAHAG
Blood Glucose Monitoring (BGM) Meters & Test Strips
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAHAI
Ketone Monitoring (Blood/Urine) Devices & Strips
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)

Keywords

  • Continuous metabolic monitoring
  • Cardiopulmonary bypass equipment
  • Organ perfusion circuits
  • Medical monitoring sensors
  • Clinical chemistry devices

Where Carbometrics is headquartered

Location

Headquarters

HQ city
Bristol
HQ country
United Kingdom
HQ region
Europe

Markets served

Carbometrics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations

Carbometrics product offering

Product offering

Core offering

Carbometrics develops i-CAM, a continuous metabolic monitoring system designed for use during cardiopulmonary bypass and organ perfusion procedures. The device delivers real-time metabolic monitoring in surgical and transplant settings, providing clinicians with continuous insight into a patient's metabolic state during critical medical procedures. The company is engaged with clinical collaborators, OEM partners, and investors to advance the product.

Product overview

Carbometrics offers i-CAM, a single unified product serving as a comprehensive continuous metabolic monitoring solution specifically designed for cardiopulmonary bypass and organ perfusion circuits in medical settings.

Differentiator

Problem solved

Functional benefit

Products and services

  • i-CAM

Companies that use Carbometrics

Customer profile

Segments1 record

Ideal customer profiles2 records

Carbometrics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Carbometrics partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights3 records

Carbometrics competitors and assessment

Company assessment

Direct peers

  • Abbott: Abbott's i-STAT system is the dominant point-of-care blood gas and metabolite analyzer used in operating rooms including during cardiac surgery. It is the closest direct analog in terms of metabolic-parameter measurement in perioperative settings and a logical competitor/partner for Carbometrics' i-CAM.
  • OPTI Medical Systems: OPTI Medical manufactures point-of-care blood gas and metabolite analyzers (OPTI CCA-TS) used in operating rooms and critical care. It competes in the same intraoperative metabolic-monitoring space targeted by i-CAM.
  • Nova Biomedical: Nova Biomedical manufactures Stat Profile and Prime Plus critical-care blood gas analyzers measuring glucose, lactate, and other metabolites at the point of care. Its products compete directly in the same perioperative metabolite-monitoring space as Carbometrics' i-CAM.
  • Siemens Healthineers: Siemens Healthineers' RAPIDPoint blood gas analyzers provide critical-care metabolite measurements in surgical and ICU settings, directly comparable to the continuous metabolic monitoring Carbometrics targets with i-CAM.
  • Werfen: Werfen's GEM Premier blood gas and metabolite analyzers are widely used in cardiac surgery and critical care, competing in the same intraoperative metabolic-monitoring category as Carbometrics' i-CAM.

Broad incumbents

  • Medtronic: Medtronic has a broad cardiac surgery and patient-monitoring portfolio (including perfusion and biosensing) that is broadly comparable to where Carbometrics' technology would integrate. It represents a major incumbent competitor and potential strategic acquirer.
  • LivaNova: LivaNova is a major manufacturer of cardiopulmonary bypass equipment and heart-lung machines, overlapping with Carbometrics' integration target. It is a logical OEM partner and potential acquirer for continuous metabolic monitoring capability within perfusion circuits.
  • Edwards Lifesciences: Edwards Lifesciences is the established leader in hemodynamic monitoring (FloTrac, ClearSight, HemoSphere) in surgical and ICU settings. It is a relevant competitor in the operating-room monitoring space and a probable strategic acquirer of complementary monitoring technology.
  • Masimo: Masimo is a leader in non-invasive patient monitoring technology (e.g., SET pulse oximetry) and has expanded into the operating room with multi-parameter monitoring. It is a broad incumbent competitor and convergence target for perioperative monitoring.
  • Terumo Cardiovascular: Terumo Cardiovascular is the leading manufacturer of cardiopulmonary bypass systems — the exact circuits Carbometrics' i-CAM is designed to integrate with. As the dominant perfusion OEM, it is the most important commercial partner and a natural strategic acquirer of continuous metabolic monitoring capability.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Carbometrics social profiles

Digital presence

Carbometrics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Carbometrics leadership team

Management profile

Number of profiles

Profiles3 records

Carbometrics funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Carbometrics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carbometrics

What does Carbometrics do?

Carbometrics develops i-CAM, a continuous metabolic monitoring system designed for use during cardiopulmonary bypass and organ perfusion procedures. The device delivers real-time metabolic monitoring in surgical and transplant settings, providing clinicians with continuous insight into a patient's metabolic state during critical medical procedures. The company is engaged with clinical collaborators, OEM partners, and investors to advance the product.

When was Carbometrics founded?

Carbometrics was founded in 2018. It employs 11 to 50 people.

Where is Carbometrics based?

Carbometrics is headquartered in Bristol, United Kingdom, in the Europe region.

Who are Carbometrics's main competitors?

Direct peers on record are Abbott, OPTI Medical Systems, Nova Biomedical, Siemens Healthineers and Werfen. Broad incumbents are Medtronic, LivaNova, Edwards Lifesciences, Masimo and Terumo Cardiovascular.

Does Carbometrics have an API?

No public API is recorded for Carbometrics.

What industry is Carbometrics in?

Carbometrics's product category is Medical Monitoring Equipment. Its primary akta.pro industry code is HLAHAHAG, Blood Glucose Monitoring (BGM) Meters & Test Strips, with a secondary code of HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT). Its NAICS code is 334510 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals